Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study

Thrombosis Journal
Takahiro Kato, Katsuhiko Matsuura

Abstract

Disseminated intravascular coagulation (DIC) is associated with high mortality in patients with sepsis. Several studies reporting that recombinant human soluble thrombomodulin (rhTM) reduced mortality in sepsis patients. This retrospective cohort study aimed to evaluate the efficacy of rhTM for patients with mild coagulopathy compared with those with severe coagulopathy. We evaluated about 90-day mortality and SOFA score. SOFA score was also evaluated for the following components: respiratory, cardiovascular, hepatic, renal and coagulation. All 69 patients were diagnosed with sepsis, fulfilled Japanese Association for Acute Medicine criteria for DIC, and were treated with rhTM. Patients were assigned to either the mild coagulopathy group (did not fulfill the International Society on Thrombosis and Haemostasis overt DIC criteria) or the severe coagulopathy group (fulfilled overt DIC criteria). The 90-day mortality was significant lower in severe coagulopathy group than mild coagulopathy group (P = 0.029). Although the SOFA scores did not decrease in the mild coagulopathy group, SOFA scores decreased significantly in the severe coagulopathy group. Furthermore the respiratory component of the SOFA score significant decreased in se...Continue Reading

References

Mar 11, 2003·Critical Care Medicine·Jean-Louis VincentUNKNOWN Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Oct 21, 2005·Chest·Sacha ZeerlederWalter A Wuillemin
Nov 12, 2005·British Journal of Haematology·Charles T Esmon
Mar 8, 2006·Critical Care Medicine·Satoshi GandoUNKNOWN Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group
Mar 3, 2007·Critical Care : the Official Journal of the Critical Care Forum·Ravindra L MehtaUNKNOWN Acute Kidney Injury Network
May 22, 2008·JAMA : the Journal of the American Medical Association·Ricard FerrerUNKNOWN Edusepsis Study Group
Dec 17, 2009·Critical Care : the Official Journal of the Critical Care Forum·Toshiaki IbaYoichi Ohno
May 17, 2011·Critical Care : the Official Journal of the Critical Care Forum·Kazuma YamakawaTakeshi Shimazu
Dec 12, 2012·Nature Reviews. Immunology·Bernd Engelmann, Steffen Massberg
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
May 2, 2013·American Journal of Respiratory and Critical Care Medicine·Russell R MillerUNKNOWN Intermountain Healthcare Intensive Medicine Clinical Program
Jan 13, 2015·Journal of Thrombosis and Haemostasis : JTH·K YamakawaT Shimazu
Apr 18, 2015·Critical Care : the Official Journal of the Critical Care Forum·Jumpei YoshimuraTakeshi Shimazu
May 15, 2015·The Journal of Surgical Research·Daisuke HashimotoHideo Baba
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Christopher W SeymourDerek C Angus
Mar 5, 2016·Thrombosis and Haemostasis·Mineji HayakawaUNKNOWN Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group

❮ Previous
Next ❯

Software Mentioned

JMP

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.